Drug intelligence / Profile preview

Curos

Development stage
Unknown
Lead developer
3M
Modality
Small Molecules
Administration
Topical
01

Overview

Curos is a line of disinfecting caps designed for the passive disinfection and protection of needleless connectors and other vascular access ports. Originally developed by Ivera Medical and subsequently acquired by 3M, the Curos system utilizes a sponge saturated with 70% isopropyl alcohol (IPA) to provide a continuous disinfecting environment. When twisted onto a connector, the device mechanically cleans the surface and maintains a chemical barrier that denatures microbial proteins, effectively killing common pathogens such as *Staphylococcus aureus* and *Escherichia coli* within one minute. Clinical data has demonstrated that the implementation of Curos caps as part of an infection control bundle significantly reduces the incidence of catheter-related bloodstream infections (CRBSIs) and central line-associated bloodstream infections (CLABSIs) compared to manual disinfection techniques. The product line includes specialized configurations such as Curos Jet for male luer connectors and Curos Tips for Foley catheter ports.

Brand names
CurosCuros JetCuros TipsCuros Stopper
Other names
Curos Disinfecting CapDisinfecting port protectorAlcohol-impregnated cap

Beyond the preview

Go deeper on Curos.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Curos.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call